Right now its in accumulation phase, thats a completely normal for a HEALTHY stock to rise.

Kanger is completely in normal phenomena. Many people are watching Kanger, waitting for MOH clinical test by the end of this month or next year. Why the big boys would enter if no confirmation yet ? Better they go play (low volume + news) to goreng.

Yong Tai is obviously a goreng counter. No confirmation yet from the vaccine manufacturer the share price already goes up ? That's the easiest way to detect goreng counter.

In my opinion, this is a changing hand transaction. Think about it, he disposed of 1.5 million lots at 0.175. Yet the price still maintains at 0.175. I noticed this lately 0.175 is very strong support. Someone queue a lot there.

Is Mr Wu done disposing his shares ? Thats 150,000,000 shares .... = 1,500,000 lots.

If you keep complaining why solution and bintai goes up, why don't you go invest there ? lol

Different with Kanger's operator, they still holding the price. Dont want this counter get manipulated too early. Only when the vaccine is ready to sell then they will stop cycling buy-sell at 0.17-0.22. You think those PP subscribers stupid ka ?

If one counter goes up like crazy WITHOUT a confirmation, thats a goreng counter. Operating playing with sentiment.

Funny la u guys compare with Bintai and Solution. Not even ONE vaccine is approved for general use yet. And you question why Bintai and Solution up ? OBVIOUSLY its a goreng counter, no confirmation yet already up ? Really ? I still remember taking profit from LU solution somewhere in august and Bintai also. It's been a goreng counter since then. Why ? The operator knows retailer will easily get attracted to "vaccine" related counter. As long there is sentiment, they will play.

Moderna just announced their efficacy rate. Cepat sikit Sinopharm >.<

byebye jutawansenyap and dont come back here. hahahaha

Administrative expenses are Rm 5.5 mil. Rugi banyak because of this.

If you invest in a counter yang ada " isi ". Don't worry, ada bisness saham surely rise.

The QR is the 3rd one. Means from August to November business. For sure it will be a loss. How do you even sell bamboo flooring during a peak of pandemic. The QR that we are waiting for is the Q4(end of Feb 2021). By that time the new bamboo RnD factory and vaccines (high chances in early 2021) will start operating. However, I did not expect that Administrative expenses are Rm 5.5 mil. That's what makes it loss so much.

This is the first time I've heard someone use a lawyer on the open market to make up a decision. >.<

@SleepingForest in this case, not even bumi vendor get the tender. So if any of you believe there are a company will gain a profit from gov distribution, you just fooled yourself.

And don't forget after Sinopharm approved in China, it needs to pass by our gov too. Again, if you want fast money (LU for no reason, roller coaster counter, goreng smpi hangus). This is not a counter for you.

Right now it might take a month for Sinopharm general public usage approval, and the new RnD factory for bamboo tech expected to be done in Q4 2020. This will bring an impact on Q1 2021.

from KJ's Twitter, he did mention gov will not appoint any middlemen for gov sector distribution. From MOSTI's letter, gov will not oppose Kanger for private distribution.

@jasonred79 don't forget to ask your lawyer about MOSTI letter to Kanger, who is the investor of PP and why they invest, how GI healthcare able to handle vaccine distribution despite only established within 1 year (no license whatsoever), and contact Kanger itself to confirm your deduction :3

The vaccine usually was developed in several years to completely working. But for Covid it's a special case, they need to rush and test it on humans is the only way to improvise it.

yeah .. since this is the first generation of vaccines, I've read it somewhere that there is no assurance it will last forever. Might need a new shot after a while. The shortest is 6 months.

Pharmaniaga/Dpharma/Solution are currently building their vaccine facilities. Kanger need zuellig power right now. Just renovate an existing zuellig facilities.

This is an opportunity for Kanger. They got the priority to buy vaccines from Sinopharm. If they act fast they can collab with Zuellig to build a factory to produce Sinopharm vaccines here.

Hari ni kerajaan telah umumkan persetujuan membeli vaccine daripada Pfizer, jadi minggu depan mungkin sentimen untuk saham-saham syarikat berkaitan vaccine.

Menerusi pembelian ini, semestinya Dpharma selaku supplier produk pharmacy di Malaysia akan mendapat manfaat. Since Dpharma dah menjadi supplier

Jadi bagaimana dengan vaccine dari negara lain yang rata-rata syarikat di bursa menandatangani perjanjian atau MOU untuk menjadi distributor?

Target pasaran vaccine ni luas, kerana selain hospital kerajaan, mereka juga target pasaran swasta. Walaupun dengan vaccine, penyakit covid masih akan wujud dan mungkin mengambil masa 2-3 tahun.

Jadi pendapat saya, tidak kira syarikat mana yang dapat vaccine. Yang paling penting syarikat mana yang boleh supply vaccine tersebut mencukupi dan syarikat logistik mana yang main peranan untuk deliver.

-From Nor Azam one of the traders that I refer to

If you research about Pfizer ... they have a quite bad reputation at western. Hmmm we shall see ..

KGB too, they provide dry ice for super cool logistics.

The problems from that article stated that Chinese developers are not as transparent as EU/US developers. The data from the inoculations still hidden. Come on Sinopharm announce the 3rd phase clinical data already ...

If it's publicly sold, I wonder if got people want to buy the Sinopharm vaccine .. 145usd = Rm 590. Plus Kanger's mark up idk how expensive it can be. Hmm hmm

Today Kanger's volume looking good. 7.3m volumes traded. 58% buy rate. price up 1 bid. It's consolidating !

@Jjkcl that obvious. But the problem is Pfizer only able to supply 12.8m doses for Malaysia next year. Gov needs to look for other providers to make it 70% of Malaysia's population by 2021.

Also, Pfizer's sample only 44,000 people. That's a quite small number compared to other vaccine providers.

No, Imbcams is an agency that Malaysia will collaborate together to do research on clinical test 3 data results from the various suppliers. It's strange though why Malaysia gov pre-order Pfizer without the approval from FDA yet. Not to mention about the logistic infrastructures.

Waitting for QR result. Then we know if Kanger is undervalue or else.

I believe Malaysian gov really interested in China vaccines(signed MoU). Its just that the clinical test 3 havent release yet. They cant announce it yet. Still waitting for that result, hoping for it to release very soon !

those pp shareholders won't dispose of their shares easily. They invest millions of ringgit. They must have trust in the future company prospect they invest in. Smart money doesn't take profit like contra players. They eat hundreds of ROI. Baru kenyang.

While we ikan bilis are predicting which counter that large fund will invest to. The clues are QR, future business, risk factors and etc.

Why institution do not quickly snap up the Private placement of 0.165?
With current price 0.185, it's already 12.12% profit.
Can anyone enlighten me?

@purple_rain institutions are waiting for most of the QR's. They won't just invest to get 12.12% easy profit. That's why it's called NovemBEAR and DecemBEAR. Large fund are hunting for their next year food.

Everyone know they plan half PP goes to Healthcare . So it is time to make announcement what Healthcare ? Matter of fact , it mentioned for future investment (not even about healthcare) .Buy lorries to depatch vaccines ? Just don't lesap as operation expenses, since 50% already been located as working capital for current existing biz .

Now hope coming QR and boost a bit to lift up the price .

@JK22 they did inform on their proposal but not in detail. However, I believe they informed the PP subscribers on their details plan since they the ones who buys it. If no details how come got investors.

new announcement today

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3107783

Looks like the PP is almost done. 2nd trance is otw.

183,237,544 new Kanger Shares subscribed. The total issued is 386,970,684 shares. After doing math, still got 203,733,140 shares left. Lelong lelong lelong ~

Even its resting place is at 0.18-0.21. Perjalanan masih jauh

Don't worry if you are a long term player, 0.2 still considered cheap. Kanger can go futher than that.

In the best-case scenario, they will nominate other PM with a strong majority. The worst case is GE. :X

Yes Ku Li must have a gang. I doubt the Belanjawan will be approve ... if ALL opposition say No. Then its a game over.

Bad politics sentiment. Good for Kanger because it's not a goreng counter. Still holding selling pressure from retailers. Look at other goreng counter what happen (RIP VIVOCOM).

"Sinopharm Group Hunan Co. Ltd. wholesales pharmaceutical products. The Company distributes chemical drug agents, antibiotics, proprietary Chinese medicines, biological chemical drugs, vaccines, medical machines, and other products"

@jasonred79 next time u want to buy something go direct to manufacturing department. ask the manager there I want to buy. Sure dapat makan kaki punya

Sinopharm Hunan Change is the subdivision for logistics and distributions. The Vaccine was developed by the China National Pharmaceutical Group Corporation (hereinafter referred to as “Sinopharm Group”). How the hell people can buy direct from lab ? Must from logistics and distributions department lah. aiyoo simple brain also cant think

@eyeHunter dog keep barking. We keep smiling.